Aurobindo buys Apotex’s EU ops
NEW DELHI: Aurobindo Pharma on Monday said it has completed the €74-million deal to acquire Apotex's commercial operations and certain supporting infrastructure in five European countries.
The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.